CRMD - CorMedix - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRMD is currently covered by 7 analysts with an average price target of $14.42. This is a potential upside of $8.72 (152.98%) from yesterday's end of day stock price of $5.7.

CorMedix's activity chart (see below) currently has 99 price targets and 93 ratings on display. The stock rating distribution of CRMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.84% with an average time for these price targets to be met of 241.9 days.

Highest price target for CRMD is $19, Lowest price target is $13, average price target is $14.42.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 19-Oct-2026. First documented stock forecast 12-Dec-2018.

Currently out of the existing stock ratings of CRMD, 20 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Mar-2022

$15

$9.3 (163.16%)

$15

14 days ago
(19-Oct-2026)

14/21 (66.67%)

$7.62 (103.25%)

353

Buy Since 08-Jan-2026

$15

$9.3 (163.16%)

$16

1 months 10 days ago
(23-Sep-2026)

0/3 (0%)

$7.31 (95.06%)

Buy Since 20-Jun-2025

$13

$7.3 (128.07%)

$14

3 months 26 days ago
(07-Jul-2026)

0/6 (0%)

$4.13 (46.56%)

Buy Since 07-Mar-2025

$14

$8.3 (145.61%)

$13

6 months 5 days ago
(28-Apr-2026)

0/3 (0%)

$6.43 (84.94%)

Buy Since 29-Sep-2020

$19

$13.3 (233.33%)

$18

6 months 5 days ago
(28-Apr-2026)

2/13 (15.38%)

$11.43 (150.99%)

925

Show more analysts

Please expand the browser size to see the chart

What is CRMD (CorMedix) average time for price targets to be met?

On average it took 242 days for the stock forecasts to be reached, with an average price target met ratio of 35.84%.

Which analyst most recently updated their price target on CRMD (CorMedix)?

Serge Belanger

Which analyst has the most public recommendations on CRMD (CorMedix)?

Serge Belanger works at NEEDHAM and has 9 price targets and 10 ratings on CRMD

Which analyst is the currently most bullish on CRMD (CorMedix)?

Chad Messer with the highest potential upside of $23.3

Which analyst is the currently most reserved on CRMD (CorMedix)?

James Lee with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?